The current prospective study included 48 eyes of 48 patients with open angle glaucoma who underwent trabeculectomy without any combined surgeries at Kanazawa University Hospital from September 2012 to August 2015. The protocol of the study adhered to the tenets of the Declaration of Helsinki and was approved by the Ethical Committee of Kanazawa University Hospital, Japan. Written informed consent was obtained from each patient.
The inclusion criteria were primary open angle glaucoma (POAG) and exfoliation glaucoma. Cases in which the EX-PRESS glaucoma filtration device (Alcon Laboratories, Inc., Fort Worth, TX, USA) was used were included. Eyes with previous trabeculotomy, laser trabeculoplasty, and cataract surgery were also included if they were performed more than 6 months before trabeculectomy. Patients with previous intraocular surgery, except glaucoma and cataract surgery as listed above, were excluded. Patients who required postoperative topical ocular hypotensive drugs and intraocular surgeries, including bleb revision or cataract surgery, were also excluded. Moreover, patients with retinal diseases including any degree of diabetic retinopathy and chorioretinal atrophy, with past retinal photocoagulation, with a long axial length (AL) (≥27.00 mm), with inadequate LSFG data having band-shaped artifacts, failure in heartbeat analysis, MBR image defects in the periphery of the measurement area, and marked decentration of the ONH, and with a short follow-up period (<6 months) were excluded.
Trabeculectomy was performed with a fornix-based conjunctival flap and a half-thickness scleral flap. Mitomycin C (0.04%) was applied for 5 minutes, and the scleral flap was closed with 10-0 nylon sutures. EX-PRESS shunts were implanted at the surgeon's discretion. Postoperatively, topical levofloxacin and betamethasone were tapered as needed. Blebs were managed by argon laser suture lysis to enhance filtration.
Patients underwent a battery of preoperative ophthalmologic tests including best corrected visual acuity, refractive status by autorefractometry, slit-lamp examination, IOP measurement using Goldmann applanation tonometry, gonioscopy, dilated fundus examination, AL measurement (OA-1000; Tomey Corporation, Nagoya, Japan), VF testing using a Humphrey field analyzer (HFA; Carl Zeiss Meditec, Dublin, CA, USA) with the 24-2 Swedish Interactive Threshold Algorithm, and LSFG. In addition, systemic blood pressure was measured by using an automated sphygmomanometer. OPP was calculated by using the following formula: OPP = 2/3 mean arterial pressure (MAP) − IOP, where MAP = diastolic blood pressure + 1/3 (systolic blood pressure − diastolic blood pressure). Measurements of IOP, blood pressure, and LSFG were repeated at 1, 3, and 6 months after surgery.